PEOPLE - Aclara BioSciences elects:
This article was originally published in Clinica
Executive Summary
Mountain View, California-based Aclara BioSciences, a company specialising in protein biomarker technology for targeted drug discovery and potentially personalised diagnostics, has elected Roy Herbst to its scientific advisory board. Dr Herbst is chief of thoracic oncology and associate professor at the University of Texas MD Cancer Center in Houston.